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Abstract 
Exercise is one of the best rehabilitation approaches for managing symptoms, restoring function, 
optimizing quality of life, promoting wellness, and boosting participation in activities of daily living 
among persons with multiple sclerosis (MS). However, persons with MS engage in low levels of health-
promoting physical activity, and this has not changed over the past 25 years, despite substantial 
expansion of the evidence-base. Such a conundrum can be addressed by identifying “limitations 
between research and practice” that prevent exercise promotion through the patient-provider 
interaction. The primary limitations that prevent exercise promotion include the inadequate quality and 
scope of existing evidence, incomplete understanding of mechanisms supporting beneficial effects of 
exercise in multiple sclerosis, and lack of a conceptual framework and toolkit for translating the 
evidence into practice. Future research that addresses those limitations will be essential for better 
informing decisions on the inclusion of exercise in the clinical care of people with MS.  
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Introduction 
Multiple sclerosis (MS) is typically described as a chronic, immune-mediated disease of the 
central nervous system (CNS) with an increasing recognition of neurodegenerative processes in its 
pathogenesis.1 The disease activity and resulting damage manifest as symptoms (e.g., fatigue and 
depression) and dysfunction (e.g., walking and cognition) that compromise quality of life (QOL) and 
participation. MS is typically treated through disease modifying drugs that target immunological 
signaling proteins (e.g., interferons, cytokines) and/or populations of immune cells (e.g., lymphocytes). 
This approach substantially controls inflammatory activity, but not neurodegenerative processes, so 
persons with MS still experience residual symptoms and dysfunction, as there is no cure for the disease.  
Participation in physical activity, particularly exercise training (see standard definitions2 in Panel 
1), increasingly has been recommended for managing symptoms, restoring function, optimizing QOL, 
promoting wellness, and boosting participation in activities of daily living in MS.3 To that end, exercise is 
one of the best rehabilitation approaches for addressing the multi-faceted problems of MS. 
Nevertheless, persons with MS engage in low levels of health-promoting physical activity, and this has 
not changed over the past 25 years, despite substantial expansion of the evidence-base. The presents a 
conundrum – exercise and physical activity offer wide-ranging benefits, but people with MS are not 
sufficiently physically active. 
This Personal View paper is derived from an International team of rehabilitation researchers 
and/or clinicians in MS and adopts the vantage point that the conundrum with exercise behavior in MS 
(i.e., lack of broad participation by people with MS despite evidence of meaningful benefits) can be 
addressed through healthcare providers, if we ameliorate keys limitations in the body of research. 
Overcoming the limitations and narrowing the gap between research and clinical practice is both timely 
and important considering the impact of the aforementioned conundrum with exercise and physical 
activity in persons with MS. We focus on three broad categories of limitations, with examples and 
possible solutions, that represent the substantive content of this paper. If these key limitations are 
addressed, healthcare providers would be positioned and empowered to tackle the barriers that impede 
knowledge translation regarding exercise as part of comprehensive care in people with MS. 
 
Effects of Exercise in MS 
There has been an increasing amount of research examining the effects of exercise training and 
participation in physical activity on consequences of MS. Collectively, the majority of exercise research 
in MS has focused on outcomes involving physical fitness, walking mobility, balance, cognition, fatigue, 
depressive symptoms, and QOL consistent with the ordering of constructs within the International 
Classification of Function model of MS pathogenesis3; this is summarised in Table 1 along with indices of 
overall methodological quality for studies included in the meta-analyses, Cochrane reviews, or 
systematic reviews. Of note, the exercise training in the existing body of research typically has taken 
place in supervised, laboratory-based settings rather than non-supervised, home-based or community 
settings. 
Physical Fitness. One systematic review and two meta-analyses have summarized the effects of 
exercise training on physical fitness outcomes in persons with MS.4-6 This is critical considering the 
deleterious effects of MS-related physiological deconditioning.7 There is evidence for small 
improvements in lower-extremity muscle strength (e.g., d=0.27) following resistance exercise training,6 
and moderate-sized improvements in cardiorespiratory fitness  (e.g., d=0.47-0.63) following aerobic 
exercise training5,6 in this population (Table 1). The improvement in aerobic fitness is seemingly large 
enough for secondary health benefits and therefore considered clinically meaningful.5 Those systematic 
reviews/meta-analyses have highlighted that many studies are underpowered; lack blinding of 
participants, therapists, and assessors; do not perform intent-to-treat analyses; and often involve 
samples with primarily relapsing-remitting MS.4-6 
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Walking Mobility. Over the past five years, there have been two meta-analyses examining the 
effects of exercise training on walking mobility outcomes in persons with MS.8,9 Overall, the studies 
demonstrated small (e.g., d=0.25)9, but beneficial (and clinically-meaningful) effects of exercise training 
on walking speed and walking endurance. Such effects were relatively homogeneous across modalities 
of exercise training (i.e., aerobic versus resistance). The recent meta-analyses8,9 confirmed the results of 
an earlier meta-analysis10 that reported small, beneficial effects of exercise on walking outcomes in MS. 
However, the recent meta-analyses have reported that there is substantial heterogeneity of exercise 
training protocols, and this limits the ability of clinicians to prescribe a specific exercise program for 
selectively improving mobility in MS.8,9 
Balance. To date, there has been one meta-analysis of exercise training effects on balance 
outcomes in persons with MS.11 That meta-analysis concluded that exercise training has a small (e.g., 
d=0.34), but statistically significant beneficial effect on balance outcomes in this population. The meta-
analysis highlighted that most studies were small and underpowered for detecting meaningful balance 
improvements, and existing randomized controlled trials did not adequately report intervention details 
or randomization procedures for enhancing the reproducibility of such research.11 Interestingly, results 
from a recent series of preliminary studies have supported balance exercise training for improving 
metrics of postural control and possibly cerebellar white and grey matter integrity (i.e., inducing 
neuroplasticity) in persons with MS.12,13  
Cognition. There has been one comprehensive systematic review examining the effects of 
exercise, physical activity, and physical fitness on cognitive outcomes in persons with MS;14 no focused 
meta-analyses are available in this area. The systematic review summarised that there is not clear 
evidence regarding a beneficial effect of exercise training on cognition in persons with MS. The current 
state of the evidence might be attributable to several methodological shortcomings of exercise trials 
(i.e., Class I and II trials), for example, lack of inclusion of cognition as a primary outcome, poorly-
designed exercise interventions, and lack of inclusion of cognitively-impaired persons with MS.14 We do 
note that recent preliminary evidence supports the beneficial effects of physical activity and exercise 
training on cognition in this population.15-17  
Fatigue. Two meta-analyses18,19 and one Cochrane review20 have examined the overall effects of 
exercise on fatigue outcomes in persons with MS. These quantitative syntheses have reported overall 
statistically significant and moderate-sized reductions in fatigue (e.g., d=0.45-0.57) following exercise 
training in persons with MS. Interestingly, one meta-analysis reported that the overall effects were 
relatively consistent across studies,18 whereas the Cochrane review reported overall heterogeneous 
effects of exercise interventions on fatigue outcomes.20 It is of considerable importance that all three 
reviews18-20 noted the lack of pre-screening participants for severe MS-related fatigue, such that the 
trials did not examine exercise as a possible treatment for fatigue in MS. Other limitations related to the 
state of the literature include underpowered studies, selective reporting of outcomes, and the broad 
range of exercise interventions across studies.18-20  
Depressive Symptoms. The search strategy and selection criteria yielded three meta-analyses 
regarding the effects of exercise training on depressive symptoms in persons with MS.21-23 The meta-
analyses reported small (e.g., d=0.28-0.37), but consistent beneficial effects of exercise on depressive 
symptoms in this population (see Table 1). Interestingly, one meta-analysis reported that the benefits of 
exercise on depressive outcomes might be particularly large if the intervention dose meets published 
physical activity guidelines.23 Of note, as is the case for the body of literature on exercise effects on 
fatigue in MS, there is an overall lack of pre-screening for individuals with elevated depressive 
symptomology or major depressive disorder. Thus, the state of the literature can only report on the 
effects of exercise on depressive symptoms, as opposed to exercise as a possible treatment for major 
depressive disorder in MS.21-23 
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QOL. There has been one recent (i.e., since 2012) systematic review regarding the effects of 
exercise training on QOL outcomes in persons with MS.24 The authors of that systematic review reported 
insufficient evidence for a conclusion regarding the effects of exercise on QOL. This is not consistent 
with the results of an early meta-analysis25 that reported small (e.g., d=0.23), but statistically significant 
improvements in QOL in this population. Importantly, several issues that might contribute to the overall 
mixed evidence involve the lack of consistent outcome measures across studies (i.e., general versus 
disease-specific QOL outcomes; use of composite QOL outcomes versus subscales).24 
Other recent studies of exercise in persons with MS indicate that there may be additional 
benefits on structures within the CNS (e.g., hippocampus),26,27 sleep quality,28 and 
cardiovascular/metabolic cormorbidity.29,30 Exercise further has been associated with reduced rates of 
MS relapses31,32 and slowed disability progression.33 The safety profile (i.e., occurrence of adverse and 
serious adverse events) in MS is comparable with the general population of adults.31 This underscores 
that participation in exercise is safe and can yield many benefits for persons living with MS (i.e., 
pleiotropic effects), and exercise has been recognized as a primary approach for restoring physical 
function34 and perhaps even modifying the disease.35,36 The evidence base has yielded guidelines for 
prescribing exercise behavior in persons with MS who have mild or moderate neurological disability 
(www.csep.ca/CMFiles/Guidelines/specialpops/CSEP_MS_PAGuidelines_adults_en.pdf)24,37 that can be 
implemented within comprehensive MS care.38 
 
Factors Affecting Exercise Participation in MS 
The proliferating body of evidence indicates small-to-moderate effects of exercise training on 
fitness, symptoms, and function in persons with MS. The problem, however, is that the majority of 
people with MS do not engage in appropriate amounts of health-promoting physical activity or exercise. 
There is consistent evidence from meta-analyses that people with MS engage in substantially less 
physical activity than healthy controls from the general population but similar to those with other 
chronic diseases.39,40 There is additional evidence from waist-worn accelerometry that persons with MS 
engage in reduced amounts of moderate-to-vigorous physical activity (MVPA) compared with the 
general population,41 and physical activity levels decrease over time as the disease develops.42 The data 
further suggest that fewer than 20% of people with MS from the U.S. engage in recommended amounts 
of MVPA necessary for health benefits compared with 40% of healthy, control samples;41,43 the rate of 
physical activity even is low for persons with mild MS who do not have significant disability.41 We further 
note that the difference in physical activity levels between MS and healthy controls has not changed 
over the past 25 years,39,40 even though the evidence base for MS-related benefits has expanded 
considerably over the past 10 years.44  
There is an obvious disconnect between evidence of benefits and rates of participation, possibly 
indicating lack of, or inefficient promotion of, exercise adoption and maintenance in this population. 
This underscores the complexity of health behavior change in MS, and the importance of identifying 
opportunities and approaches that can facilitate long-term behavior change (e.g., exercise interventions 
that include behavioral components in MS). The disconnect presents a conundrum – exercise and 
physical activity offer wide-ranging benefits, but people with MS are not sufficiently physically active. 
That is, exercise cannot be effective if people do not do it. This disconnect is critically important, as the 
chasm between benefits and participation may be even larger in MS than the general population, and 
the roles of exercise and physical activity might be most important in a disease wherein people are 
facing functional declines and other outcomes.45 The conundrum is seemingly not linked with 
compliance regarding specific exercise programs, as over 80% of people with MS who are enrolled in 
randomized controlled trials (RCTs) of structured, supervised exercise training complete the prescribed 
regimen.31  
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There has been considerable interest in identifying determinants (i.e., variables that correlate 
with behavior and that might serve as targets of interventions for changing behavior) of exercise and 
physical activity behavior in MS.46,47 The rate of physical activity participation in MS may reflect physical 
limitations associated with ambulatory disability, symptoms of MS (e.g., depression, fatigue), 
environmental barriers (e.g., lack of access to facilities), and/or psychosocial factors related to behavior 
change (e.g., self-monitoring, self-efficacy, goal setting, social support) as summarized in a systematic 
review.46 There has been further interest in the application of behavior change theory for studying 
determinants of physical activity behavior in MS, and this body of research has largely focused on 
variables from social-cognitive theory (SCT).47,48 Of note, SCT recognizes the interaction between the 
person and environment (physical and social) when considering behavior change, and this underscores 
the importance of identifying environmental facilitators that permit successful application of programs 
for behavior change among persons with MS.  
 We propose that the underutilisation of physical activity in people with MS, despite supporting 
evidence of its benefits, can be overcome by ameliorating three key limitations in exercise research: 
quality and scope of existing evidence, mechanisms supporting beneficial effects of exercise in multiple 
sclerosis, and conceptual framework and toolkit for translating the evidence.  
 
Quality and Scope of Existing Evidence 
There is evidence from NIH-defined Phase I and II clinical trials indicating that exercise has 
substantial benefit for those with MS.49 Yet, this evidence has limitations for specific indications that 
limit translation of knowledge into clinical practice (see Table 1). First of all, there are no effectiveness 
trials (i.e., NIH-defined Phase III clinical trials) of exercise and its benefits in MS, and few studies focusing 
on the dose-response association between exercise training parameters (e.g., intensity and/or 
frequency) and MS outcomes.50,51 Another limitation in current research on outcomes of exercise 
training is derived from samples that are not prescreened for the presence of a specific symptom or 
dysfunction associated with MS. For example, there are over 20 RCTs indicating that exercise training 
improves measures of fatigue (e.g., d=0.45)18 and/or depressive (e.g., d=0.36)21 symptoms. The two 
papers that included systematic reviews of inclusion criteria and sample characteristics indicated that 
few, if any, of the studies actually included persons with severe or impactful fatigue and clinical 
depressive symptomology or even major depressive disorder. 20,22 This is important considering the high 
prevalence and burden of fatigue and depression in MS52 that further might influence the high rates of 
physical inactivity in this population.53 There may be variability in outcomes of exercise training by MS 
phenotypes, yet such heterogeneity has not been systematically examined in the existing body of 
research. Indeed, the existing research has often included samples of persons who have relapsing-
remitting MS (RRMS) and/or mild or moderate MS-related disability;18,20,49 this research has further 
focused on relatively healthy samples without comorbid conditions that are common in MS.54 The 
cumulative evidence has yielded publicly-available guidelines for exercise training in adults with RRMS 
who have mild or moderate disability (Table 2).24,37  The body of research is substantially weaker when 
focusing on progressive forms of MS and those with severe disability.55-57 We note, in particular, that 
reviews of the literature report insufficient evidence for conclusions regarding the benefits of exercise in 
progressive forms of MS and those with severe disability.55-57 This is particularly relevant, given that 
persons with progressive MS who have severe ambulatory disability are significantly less physically 
active than persons with RRMS.41 This cohort represents a segment of the MS population who might 
benefit the most from exercise training.49  
Alarmingly, the evidence is not sufficiently developed in scope whereby providers would have 
confidence in applying exercise training for managing symptomatic and functional outcomes in 
progressive forms of MS and persons with severe disability status.56 The evidence further is not 
substantial enough for developing evidence-based prescriptive guidelines in these segments of the MS 
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population. This is an enormous limitation that must be overcome, as most disease modifying drugs are 
not approved for progressive MS and/or are ineffective in later stages of RRMS (e.g., Expanded Disability 
Status Scale score of 4.0 or greater).58,59 The focus on the benefits of exercise training among these 
segments of the MS population is sorely needed for knowledge translation within clinical practice. 
Future research must target and recruit samples of participants a priori who present with an actual 
disease-specific problem when studying the benefits of exercise in MS. This is key for knowledge 
translation whereby providers can prescribe exercise for a specific problem in person with MS. 
There is a noteworthy absence of clearly-defined primary endpoints, as illustrated in RCTs of 
exercise training and depression wherein only 1 of 12 studies identified depression as a primary 
endpoint.22 This is a significant problem as clinicians are unlikely to recommend or prescribe exercise for 
treating a significant and specific problem – if the evidence does not support such a specific application 
and indication. This problem may further result in the effects of exercise being underestimated (i.e., 
floor effects) in RCTs, and warrants further study. There further is a lack of consensus regarding a 
problem-specific set of validated, core outcomes for inclusion in exercise trials and this might serve as a 
roadblock in the translational pipeline. There is an increasing emphasis on clinically meaningful effects 
of interventions in MS, and yet few RCTs of exercise training properly reflect on whether the changes in 
focal outcomes signal an improvement that has value in a patient’s life (i.e., clinical relevance based on 
benchmarks of meaningful change). The aforementioned problems should be addressed in future 
research geared towards strengthening the quality of the knowledge base for translation into clinical 
practice.  
Numerous other problems beset the quality of the existing research. For example, there is very 
limited evidence regarding the durability or sustainability of exercise effects on consequences of MS; 
this was highlighted by a seminal Cochrane Review over 10 years ago,60 and continues to be a major 
limitation.49 The lack of knowledge regarding the sustainability of exercise effects on fitness, symptoms, 
and function in this population brings into question whether or not exercise can exert a meaningful 
disease-modifying change in those outcomes. The provision of long-term follow-up outcomes related to 
activities of daily living in future exercise trials might serve to instill confidence in providers for 
promotion of appropriate exercise programs in MS patients. Other problems include underpowered 
studies21 with small sample sizes (e.g., mean sample size in RCTs = 50, range of 14-130),44 and many 
studies do not include blinded assessors or intent-to-treat analyses18,20,22 nor focus on metrics of Reach 
(e.g., number, proportion, or representativeness of those who participate), Effectiveness (e.g., change in 
appropriate outcomes including QOL), Adoption (e.g., number, proportion, or representativeness of 
settings/clinicians who participate), Implementation (e.g., extent, time, and costs of consistent program 
delivery), and Maintenance (e.g., long-term effects and attrition) (RE-AIM principles)61 when designing 
and evaluating trials.  
  There are other issues that limit the scope of the available research involving exercise and MS. 
For example, the majority of people with RRMS are on a disease modifying drug, yet such information is 
not systematically collected, reported, and/or statistically accounted for in RCTs of exercise training; 
there are similar problems regarding symptomatic agents and other rehabilitation therapies besides 
exercise. This presents a problem, as we do not have a clear understanding of the benefits of exercise in 
the context of disease modifying drug usage for consideration by providers in the promotion on exercise 
among people with MS. There is as of yet no consideration of the role of exercise training as an add-on 
or stepped-care therapy in MS. For example, cognitive behavior therapy is a common approach for 
managing depression in MS, but it alone is not always effective62 and exercise could be added as a 
stepped-care approach for therapy. There is very little known about exercise within the context of 
relapses.63 For example, should a patient discontinue exercise during a relapse for safety? When and 
how should exercise be reinitiated after resolution of a relapse and is exercise only suitable after certain 
types of relapses? The aforementioned problems should be the focus of future research for broadening 
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the scope of the knowledge base for translation into clinical practice. Indeed, high quality research in 
this area might provide a stronger evidence base whereby providers would be more likely to prescribe 
exercise along with adjuvant pharmacological or other rehabilitative therapies for improving function in 
this population. 
 One final issue associated with the quality and scope of existing research is a glaring lack of 
knowledge regarding how to maximize adherence and compliance with exercise training programs.31,44 
Future research studies might consider integrating approaches based on behavior change theories such 
as SCT within exercise training programs for maximizing adherence/compliance and long-term 
maintenance. Such approaches could further strengthen the patient-provider interaction by providing 
guidance regarding how patients can optimally initiate and maintain physical activity behavior over time 
for realizing its possible benefits.   
 
Mechanisms Supporting Beneficial Effects of Exercise in MS 
The vast majority of research on outcomes of exercise training has focused on symptoms, 
functions, and QOL, whereas there is limited research on the mechanisms of exercise training effects in 
MS. That is, we know that exercise exerts many benefits in MS, but we do not know how or why. The 
examination of biological factors for exercise training effects in this population is critical for increasing 
the confidence of healthcare providers for promoting exercise in MS patients. Healthcare providers still 
have doubts about the biomedical efficacy of exercise in MS, and understanding the mechanisms of 
exercise effects is important for convincing providers about the biological basis for exercise effects in 
MS. There are an increasing number of studies examining neural and molecular mechanisms of exercise 
and physical activity in animal models of MS (e.g., experimental autoimmune encephalomyelitis or 
EAE).64 However, such animal studies are often inconclusive, difficult to interpret, and might undermine 
the promotion of exercise in persons with MS by providers who are skeptical of the actual clinical 
translation of the animal work.  
 There have been some efforts toward studying mechanisms of exercise effects in people with 
MS by focusing on immune cells and neurotrophic factors in peripheral blood samples;3 the assumption 
is that samples taken from the periphery reflect ongoing pathophysiology in the CNS. The existing 
research, however, provides a conflicting picture of changes in immune and neurotrophic factors with 
exercise in humans with MS,3 and further does not consider that MS is typically an acute, episodic 
disease (e.g., RRMS) that involves intermittent bursts of inflammation, although there is some ongoing, 
chronic inflammation.1 To that end, future clinical trials might overcome the limitations by collecting 
peripheral blood samples with acute bouts of exercise during a relapse (i.e., period wherein there is 
disruption of the blood-brain barrier allowing lymphocyte migration into CNS) or cerebral spinal fluid 
with long-term exercise training.  
 There  is emerging evidence supporting that exercise may promote neuroplasticity in persons 
with MS. Several cross-sectional studies suggest that aerobic fitness/physical activity are positively 
associated with volumes of subcortical grey matter structures (e.g., hippocampus and basal ganglia) in 
MS.65,66 Other case studies indicate that aerobic exercise training may increase hippocampal volume and 
integrity in this population.26,27 These structural brain observations may explain exercise training effects 
on ambulation and cognition,67 but we do not have evidence from Phase II RCTs nor ontological 
mechanisms for explaining why the structural changes occur with exercise training in MS. This likely 
represents a key limitation in clinical translation of exercise, as healthcare providers seek firm, 
mechanistically-derived evidence for making recommendations regarding any approach for treating MS. 
Without a clear picture of underlying mechanisms resulting in testable theoretical frameworks, clinicians 
are left wondering why exercise would work for improving outcomes in MS. This might further reflect a 
problem with translation whereby patients with MS might seek a mechanistic explanation or rationale 
for exercise benefits. Clearly, stronger research in this area is needed to provide more convincing 
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evidence for possible mechanisms of exercise effects on the CNS in MS (i.e., Is exercise a 
countermeasure for CNS decline in MS?). 
 
Conceptual Framework and Toolkit for Translating the Evidence 
The development of a strong knowledge base supported by mechanisms with substantial scope 
for application across MS phenotypes (i.e., limitations 1 and 2) is a first step in exercise adoption and 
adherence among people with MS. We further need a detailed understanding of the potential within the 
patient-provider interaction (i.e., conceptual framework) and an associated toolkit for translating 
knowledge on exercise into practice through providers. This would require a focus on the healthcare 
provider as an external agent for translation of knowledge about exercise and its promotion through 
clinical care of MS patients. For example, the patient-provider interaction might represent an 
opportunity for inclusion of advice on benefits as well as counseling on barriers and facilitators into the 
promotion and prescription of exercise in MS (e.g., clinicians may target self-efficacy via social 
persuasion for promoting exercise behavior change in a patient for management of fatigue). 
The translation of evidence into practice (e.g., comprehensive care of MS by healthcare 
providers) might be a key factor undermining the adoption and maintenance of exercise behaviors in 
persons with MS. That is, research indicates that people with MS seek information on behavioral 
approaches for managing MS and optimizing wellness, particularly exercise and diet.68 One initial survey-
based study of 930 Americans with MS indicated that 34-50% of people, depending upon the healthcare 
setting, wanted substantially more information about exercise and nutrition in the context of healthcare 
services.69 Based on this early work, more recent qualitative research has indicated that people with MS 
want the promotion of exercise behavior through interactions with healthcare providers.70,71 The group 
of healthcare providers is supportive of exercise promotion as part of comprehensive MS healthcare.72 
Collectively, the healthcare setting and associated providers, including neurologists, 
(neuro)psychologists, nurses, and occupational and physical therapists, are strategically positioned for 
addressing issues surrounding exercise adoption and adherence in MS,38 and yet providers may not have 
the knowledge base, models, tools, or resources for capitalizing on this opportunity. The notion of 
focusing on the provider for promoting exercise is not necessarily new,73 but represents a fresh 
perspective in MS that is particularly suited for this population considering the importance placed on 
ongoing, comprehensive care through the patient-provider interaction. 
Of note, there is quantitative and qualitative evidence that people with MS seek and want 
support for exercise promotion by providers within the context of comprehensive care,70 particularly 
through face-to-face interactions.71 Qualitative data from two papers of the same sample of persons 
with MS (N=50) in the USA70,71  indicated a need for (a) information on the benefits of exercise and its 
prescription, (b) materials supporting home and community exercise, and (c) tools for initiating and 
maintaining exercise behavior through interactions with healthcare providers across levels of disability 
and physical activity. Providers too are interested in, and capable of, addressing the unmet needs of 
people with MS for exercise promotion.72  Qualitative data from Neurologists, Occupational Therapists, 
Physical Therapists and Nurses (N=44) in the USA indicated that providers identify opportunities for 
exercise promotion through the healthcare system and comprehensive team during clinical 
appointments.72 Providers particularly seek professional and service training for information on benefits 
of exercise, provision of protocols for exercise promotion, and prescriptive exercise guidelines for 
promoting behavior change among people with MS.72  
The aforementioned research is consistent with a participatory action framework of involving 
patients and providers into the process of forming an action plan for promoting exercise through the 
patient-provider interaction.74,75 Such information must now be organized into a framework through 
concept mapping (i.e., diagram that represents relationships among ideas) that will yield a toolkit 
supporting knowledge translation consistent with implementation science (i.e., study of methods for 
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uptake of research findings into routine healthcare in clinical contexts). This is of considerable 
importance given that emphasis on the putative benefits of exercise in persons with MS is a relatively 
recent phenomenon, as clinicians have been prescribing rest for improving function and symptoms in 
this population for decades.76 Indeed, despite relatively weak evidence, energy conservation techniques 
for reducing fatigue are still commonly practiced in MS rehabilitation settings.77 Perhaps the dogmatic 
shift from ‘exercise is fatiguing’ toward ‘exercise reduces fatigue’ is slowly being adapted, given the 
recent surge of evidence supporting the benefits of exercise in this population.18-20 Such a shift in clinical 
practice mirrors that which is currently occurring in persons with stroke.78 This underscores the need for 
carefully completed evidence-based practice guidelines supporting the beneficial effects of exercise in 
MS for the development of toolkits for improving exercise promotion by healthcare providers.  
 
Moving Toward Knowledge Translation into Clinical Practice 
The notion of knowledge translation involves moving research findings into practice, and there 
are five main themes around knowledge translation:79 1. What should be transferred? 2. To whom 
should research knowledge be transferred? 3. By whom should research knowledge be transferred? 4. 
How should research knowledge be transferred? 5. With what effect should research knowledge be 
transferred?. We believe that addressing the three key limitations in research on exercise training in MS 
will advance our knowledge regarding four of the five themes involving knowledge translation. For 
example, tackling the first and second limitations will be necessary for addressing the question of “what 
research knowledge should be transferred?”, whereas targeting the first limitation will be required for 
answering “to whom should research knowledge be transferred?”. Focusing on the third limitation will 
provide direction on “How” and “By whom” research knowledge should be transferred. Those three 
limitations are interlaced, and could be addressed through the formation of an international 
collaborative research network that improves the translational research pipeline for moving knowledge 
into practice, as undertaken in stroke.80 The development of collaborative opportunities with 
implementation scientists will be essential for addressing the fifth theme involving an approach and 
process for evaluating the effect of knowledge translation as it relates to exercise and MS. Collectively, 
the limitations we identified have direct relevance for knowledge translation on exercise promotion in 
persons with MS. This multifaceted approach will be critical for facilitating and supporting the 
integration of research on the beneficial effects of exercise into the clinical practice of those providing 
care to persons with MS (i.e., implementation science). Importantly, these 5 main themes are critical for 
delineating a better roadmap for future research. 
 
Conclusions and Future Directions 
Exercise is one of the best rehabilitation approaches for managing symptoms, restoring 
function, optimizing QOL, promoting wellness, and boosting participation in activities of daily living in 
MS. Nevertheless, there is a disconnect between the published evidence of benefits from exercise 
training in persons with MS and the alarming rates of physical inactivity in this population. Although this 
conundrum is likely multifactorial, the patient-provider interaction is an understudied and especially 
critical aspect for promoting physical activity participation and increasing the likelihood that persons 
with MS will realize exercise-related benefits on fitness, symptoms, and function. Addressing gaps 
between research and practice for improving promotion of exercise via the patient-interaction could, in 
turn, influence other explanatory factors for the lack of exercise participation in this population (i.e., 
clinicians helping to improve self-efficacy via social persuasion). 
We highlight that future research can improve upon the quality and scope of existing evidence 
regarding the benefits of exercise training in MS for better informing clinical care of people with MS by 
addressing the priorities identified in a recent paper on future research in MS.51 For example, future 
research efforts must pre-screen participants based on having the consequence that is the primary 
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study outcome (i.e., targeting severely fatigued persons with MS for an exercise intervention for 
reducing fatigue). This is critical considering that such disease-related consequences are common and 
highly burdensome in this population. Such interventions further should be adequately powered and 
include blinded outcome assessors. Indeed, this may involve designing more specific, targeted exercise 
interventions in representative MS populations for truly understanding the impact of exercise training 
on focal outcomes. As there is currently a dearth of evidence regarding the effects of exercise training in 
persons with progressive MS with severe ambulatory disability, there must be a broadened scope of 
exercise research that examines possible benefits in this cohort. In addition, future research efforts 
should delineate how to optimize adherence and compliance within the context of a given intervention, 
such that persons with MS can maximally realize the potential benefits of exercise training. Collectively, 
addressing these limitations could improve promotion of exercise via the patient-provider interaction. 
Stronger research efforts in this area are needed to provide more convincing evidence for possible 
mechanisms of exercise effects on the CNS in MS; this might strengthen the confidence of healthcare 
providers for prescribing exercise in MS patients. Nevertheless, we underscore the importance of 
knowledge translation and implementation science for directly bridging the data arising from exercise 
research on the one hand and clinical practice in this population on the other. This includes better 
equipping both providers and people with MS for adopting exercise behavior as an approach for 
managing the numerous debilitating consequences of MS.  
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Panel 1: Definitions of physical activity, exercise, and fitness.2 
 
Physical activity = any bodily movement produced by contraction of skeletal muscles that results in a 
substantial increase in energy expenditure over resting levels. 
 
Exercise = subset of physical activity that is planned, structured, and repetitive with the objective of 
improving or maintaining physical fitness. 
 
Physical fitness = set of characteristics or attributes that people have or achieve that describe the 
capacity for performing physical activity.  
 
  
18 
 
Panel 2: Search strategy and selection criteria. 
  
 References for this Personal View were identified by searches of PubMed, Google Scholar, 
Scopus, and CINAHL between January, 2012 and July, 2017, and references from relevant articles. The 
search terms were ‘multiple sclerosis’, ‘exercise’, ‘physical activity’, ‘physical fitness’, and 
‘rehabilitation.’ We focused on meta-analyses, Cochrane reviews, and narrative, systematic reviews in 
order to capture the broad scope and overall effects of exercise on various consequences of MS, given 
that separately reviewing over 60 individual clinical trials of exercise in MS would extend beyond the 
scope of the current paper. We only reviewed papers that were published in English. The final reference 
list was generated on the basis of relevance to the focus of this Personal View.  
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Table 1: Effects of exercise training in persons with MS. 
Outcome Study Design Primary Purpose 
Number 
of 
Studies 
Included 
Primary 
Results/Effect Sizes 
Quality Indices 
Limitations of 
Research Body 
Physical 
Fitness 
Kjølhede et 
al., 20124 
Systematic 
Review 
Effects of 
resistance exercise 
on muscular 
strength outcomes 
in MS 
16 
7-21% improvement 
in lower limb MVC; 
20-50% 
improvement in 
lower limb 1-RM 
 
d-values: NR 
Mean PEDro score = 
5.0 
Small sample sizes 
(risk of Type II 
error); lack of 
blinded assessors 
Langeskov-
Christensen 
et al., 20155 
Meta-Analysis 
Effects of exercise 
on aerobic 
capacity in MS 
17 
Moderate 
improvements in 
VO2peak (d=0.63) 
Mean PEDro score = 
5.5 
Lack of severely 
disabled samples 
Platta et al., 
20166 
Meta-Analysis 
Effects of exercise 
training on fitness 
in MS 
20 
Improvements in 
muscular fitness 
(d=0.27) and 
cardiorespiratory 
fitness (d=0.47) 
Combined exercise:  
*Mean PEDro score 
= 6.6 
 
Aerobic exercise: 
*Mean PEDro score 
= 7.2 
 
Resistance exercise: 
*Mean PEDro score 
= 6.7 
Overall lack of 
studies reporting 
fitness measures; 
low quality 
outcome 
measures; lack of 
severely disabled 
samples; lack of 
concealed 
allocation; lack of 
blinded 
participants, 
assessors, 
therapists, lack of 
ITT analyses 
  
Walking 
Mobility 
Pearson et 
al., 20158 
Meta-Analysis 
Effects of exercise 
on mobility in MS 
13 
Overall clinically 
meaningful 
improvements in 
10mWT (17%) and 
2MW (19%); Overall 
significant, but non-
*Mean PEDro score 
= 6.0 
Heterogeneous 
interventions; no 
dose-response 
studies; lack of 
comparisons of 
exercise 
20 
 
clinically meaningful 
improvements in 
T25FW, 6MW 
 
d-values: NR 
modalities 
Learmonth 
et al., 20169 
Meta-Analysis 
Effects of 
physiotherapy 
treatment on 
walking 
performance in 
MS 
21 
Improvements in 
walking outcomes 
(d=0.25); similar 
across treatment 
protocols 
*Mean PEDro score 
= 6.0 
Heterogeneous 
treatment 
protocols 
  
Balance 
Paltamaa et 
al., 201211 
Meta-Analysis 
Effects of 
physiotherapy 
interventions on 
balance outcomes 
in MS 
7 
Small, but 
statistically 
significant beneficial 
effects on balance 
(d=0.34) 
Mean Van Tulder 
score = 4.4 
 
PEDro score: NR 
Small, 
underpowered 
studies; lack of 
blinding; lack of 
reporting of 
intervention and 
randomization 
protocols 
  
Cognition 
Sandroff et 
al., 201614 
Systematic 
Review 
Effects of exercise, 
physical activity, 
physical fitness on 
cognition in MS 
26 
Conflicting evidence 
for exercise effects; 
preliminary 
evidence supporting 
beneficial effects of 
physical activity and 
physical fitness on 
cognition 
 
d-values: NR 
Exercise: 
*Mean PEDro score 
= 7.0 
 
Physical activity: 
*Mean PEDro score 
= 6.0 
 
Physical fitness: 
Mean PEDro score = 
N/A 
Cognition not 
included as 
primary outcome; 
poorly-developed 
exercise 
interventions; lack 
of cognitively-
impaired samples 
  
Fatigue 
Pilutti et 
al., 201318 
Meta-Analysis 
Effects of exercise 
training on fatigue 
in MS 
17 
Consistent, 
moderate 
reductions in fatigue 
(d=0.45) 
*Median PEDro 
score = 6.0 
Heterogeneous 
interventions; lack 
of progressive MS 
samples; persons 
21 
 
not pre-selected 
for fatigue; lack of 
blinded assessors; 
lack of ITT 
analyses 
Asano et 
al., 201519 
Meta-Analysis 
Effects of exercise, 
education, and 
pharmacotherapy 
on fatigue in MS 
25  
 
(10 of 25 
studies 
on 
exercise) 
Moderate 
reductions in fatigue 
(d=0.57), similar to 
effects of 
educational 
interventions 
(d=0.54) 
Overall Risks of Bias: 
Selection bias; lack 
of concealed 
allocation; 
incomplete 
outcomes reported; 
selective reporting 
of outcomes 
 
PEDro score: NR 
Heterogeneous 
interventions; lack 
of pre-screening 
for fatigued 
persons; lack of 
concealed 
allocation; 
incomplete 
outcome 
reporting; 
selective 
reporting of 
outcomes 
Heine et al., 
201520 
Cochrane 
Review 
Effects of exercise 
therapy on fatigue 
in MS 
45 
Moderate 
reductions in fatigue 
(d=0.53) 
Mean PEDro score = 
5.2 
Underpowered 
studies; lack of 
recruiting based 
on having severe 
fatigue; lack of 
therapies 
targeting fatigue 
  
Depressive 
Symptoms 
Ensari et 
al., 201421 
Meta-Analysis 
Effects of exercise 
training on 
depressive 
symptoms in MS 
13 
Small, consistent 
improvements in 
depressive 
symptoms (d=0.36) 
Mean PEDro score = 
5.8 
Lack of blinded 
assessors; lack of 
primary focus of 
interventions; lack 
of pre-screening 
for depression 
Dalgas et 
al., 201522 
Meta-Analysis 
Effects of exercise 
training on 
depressive 
symptoms in MS 
12 
Small, consistent 
improvements in 
depressive 
symptoms (d=0.37) 
Mean PEDro score = 
5.6 
Heterogeneous 
interventions; 
depression not 
primary outcome; 
no studies on 
22 
 
MDD; lack of 
progressive MS 
samples; lack of 
control for anti-
depressant 
medications 
Adamson et 
al., 201523 
Meta-Analysis 
Effects of exercise 
training on 
depressive 
symptoms in 
persons with 
neurological 
disorders 
23 
 
(13 of 23 
studies 
on MS) 
Small, consistent 
improvements in 
depressive 
symptoms (d=0.28); 
larger effects when 
interventions meet 
physical activity 
guidelines 
Mean PEDro score 
(MS studies) = 5.5 
Lack of studies on 
MDD; lack of 
blinded 
participants, 
therapists, 
assessors; lack of 
AE reporting; 
inclusion of non-
depressed 
samples 
  
QOL 
Latimer-
Cheung et 
al., 201324 
Systematic 
Review 
Effects of exercise 
training on fitness, 
mobility, fatigue, 
and health-related 
QOL in MS 
26 
Conflicting evidence 
for effects on QOL 
 
d-values: NR 
Aerobic exercise: 
*Mean PEDro score 
= 7.5 
 
Resistance exercise: 
*Mean PEDro score 
= 8.5 
 
Combined exercise: 
*Mean PEDro score 
= 7.7 
 
Other exercise: 
*Mean PEDro score 
= 7.0 
Overall lack of 
reporting on 
safety of exercise 
training; 
heterogeneous 
interventions; 
equal monitoring 
of persons in 
exercise and 
control conditions 
Note: *PEDro scores ≥ 6.0 are indicative of good methodological study quality; 1-RM=1-repetition maximum; 2MW=Two-minute walk; 6MW=Six-minute walk; 10mWT=Ten 
meter walk test; AE=Adverse event; ES=Effect size; ITT=Intent-to-treat; MDD=Major depressive disorder; MS=Multiple sclerosis; MVC=Maximal voluntary contraction; NR = not 
reported; PEDro=Physiotherapy Evidence Database; QOL=Quality of life; SMD=Standardized mean difference; T25FW=Timed 25-foot walk; VO2peak=Peak oxygen consumption; 
Effect sizes interpreted as small, moderate, and large based on Cohen’s d-values of 0.2, 0.5, and 0.8, respectively. 
 
23 
 
 
